ManRos' Unattributed - II Round

ManRos raised a round of funding on September 29, 2015. Investors include Credit Agricole.

ManRos Therapeutics is a biotechnology company that develops molecules in the treatment of cystic fibrosis, neurodegenerative diseases and polycystic kidney disease.…

Articles about ManRos' Unattributed - II Round: